SCHEMBL21976457

SCHEMBL21976457

C=C(CC1(O)CCN(C(=O)c2ccc(N)cc2)CC1)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ GAA P10253 2/20 0.45
▸ LMNA P02545 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ MLYCD O95822 1/20 0.43
▸ CYP3A4 P08684 5/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ MGLL Q99685 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16084362 0.77 PKLR (0.50) ALDH1A1SMN1; SMN2GAALMNACA12
SCHEMBL14320380 0.75 GRM3 (0.58) ALDH1A1SMN1; SMN2LMNACA12CA1
SCHEMBL18053843 0.75 CA12 (0.57) ALDH1A1CA12CA1CA2CA7
SCHEMBL16051041 0.74 PKLR (0.58) CA12CA1CA2CA7CA9
SCHEMBL17054868 0.73 CA12 (0.55) ALDH1A1SMN1; SMN2LMNACA12CA1
SCHEMBL16049701 0.73 AVPR1A (0.58) ALDH1A1LMNACYP3A4CYP2C9CHRM2
SCHEMBL14117658 0.72 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2GAALMNACA12
SCHEMBL16234790 0.72 CA12 (0.58) ALDH1A1SMN1; SMN2GAALMNACA12
SCHEMBL16084126 0.72 PKLR (0.46) ALDH1A1SMN1; SMN2GAALMNACA12
SCHEMBL16084138 0.72 PKLR (0.52) ALDH1A1SMN1; SMN2GAALMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970189-B1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS INC (US) 2020-05-06 — — EP disclosed
Send feedback